Arkolith/Insider Trading/RCKT/Form 4

Shah Gaurav

CEO, DirectorROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Feb 13, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2025Grant(A)82K—$0789K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 11, 2025Grant(A)243K—$0243K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-004296) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML